• 1
    Hirsch HH. Polyomavirus BK nephropathy: A (re-)emerging complication in renal transplantation. Am J Transplant 2002; 2: 2530.
  • 2
    Hirsch HH, Brennan DC, Drachenberg CB et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005; 79: 12771286.
  • 3
    Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611623.
  • 4
    Ramos E, Drachenberg CB, Papadimitriou JC et al. Clinical course of polyomavirus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 21452151.
  • 5
    Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyomavirus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103109.
  • 6
    Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP. BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68: 18341839.
  • 7
    Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1: 12531257.
  • 8
    Crowder CD, Gyure KA, Drachenberg CB et al. Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. Am J Transplant 2005; 5: 11511158.
  • 9
    Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1: 12571260.
  • 10
    Knowles WA, Pipkin P, Andrews N et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71: 115123.
  • 11
    Hirsch HH. BK virus: Opportunity makes a pathogen. Clin Infect Dis 2005; 41: 354360.
  • 12
    Randhawa P, Uhrmacher J, Pasculle W et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol 2005; 77: 238243.
  • 13
    Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488496.
  • 14
    Nickeleit V, Klimkait T, Binet IF et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 13091315.
  • 15
    Comoli P, Binggeli S, Ginevri F, Hirsch HH. Polyomavirus-associated nephropathy: Update on BK virus-specific immunity. Transpl Infect Dis 2006; 8: 8694.
  • 16
    Bohl DL, Storch GA, Ryschkewitsch C et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 22132221.
  • 17
    Comoli P, Azzi A, Maccario R et al. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 2004; 78: 12291232.
  • 18
    Comoli P, Basso S, Azzi A et al. Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. J Am Soc Nephrol 2003; 14: 31973204.
  • 19
    Ginevri F, De Santis R, Comoli P et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003; 75: 12661270.
  • 20
    Brennan DC, Agha I, Bohl DL et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582594.
  • 21
    Drachenberg CB, Papadimitriou JC, Wali R et al. Improved outcome of polyomavirus allograft nephropathy with early biopsy. Transplant Proc 2004; 36: 758759.
  • 22
    Funk GA, Steiger J, Hirsch HH. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis 2006; 193: 8087.
  • 23
    Trofe J, Hirsch HH, Ramos E. Polyomavirus-associated nephropathy: Update of clinical management in kidney transplant patients. Transpl Infect Dis 2006; 8: 7685.
  • 24
    Chen Y, Trofe J, Gordon J et al. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 2006; 80: 34953505.
  • 25
    Hammer MH, Brestrich G, Andree H et al. HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity. Am J Transplant 2006; 6: 625631.
  • 26
    Binggeli S, Egli A, Dickenmann M, Binet I, Steiger J, Hirsch HH. BKV replication and cellular immune responses in renal transplant recipients. Am J Transplant 2006; 6: 22182219.
  • 27
    Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001; 184: 14941495; author reply 1495–1496.
  • 28
    Sester U, Gartner BC, Wilkens H et al. Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation. Am J Transplant 2005; 5: 14831489.
  • 29
    Randhawa PS, Popescu I, Macedo C et al. Detection of CD8 + T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients. Hum Immunol 2006; 67: 298302.
  • 30
    Binggeli S, Egli A, Steiger J, Hirsch HH. BKV-specific cellular immune response to VP1 and large T-antigen after polyomavirus-associated nephropathy (Abstract 83). World Transplant Congress 2006, vol 6. Boston , MA : Am J Transplant 2006; 6: 94.
  • 31
    Bunde T, Kirchner A, Hoffmeister B et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 2005; 201: 10311036.
  • 32
    Krymskaya L, Sharma MC, Martinez J et al. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 2005; 79: 1117011178.
  • 33
    Drachenberg CB, Papadimitriou JC, Hirsch HH et al. Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load. Am J Transplant 2004; 4: 20822092.